MECHANISTIC STUDY OF APOPTOTIC CELL DEATH AND INVASION POTENTIAL USING SIGNAL TRANSDUCTION INHIBITORS IN THE ONCOGENE-TRANSFECTED HUMAN CELLS
MECHANISTIC STUDY OF APOPTOTIC CELL DEATH AND INVASION POTENTIAL USING SIGNAL TRANSDUCTION INHIBITORS IN THE ONCOGENE-TRANSFECTED HUMAN CELLS
批准号:
10670415
负责人:
NAKANO Shuji
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although src or ras oncogene induces transformation, their precise roles in the apoptotic machinery and invasion remain to be clarified. We examined the role of these oncogenes on the detachment-induced apoptosis termed anoikis and invasion potential, using HAG-1 human epithelial cell lines transfected with v-src or activated ras. Non-tumorigenic parental, mock-transfected, and ras-transfected HAG-1 cells underwent anoikis. By contrast, tumorigenic, v-src-transformed cells did not exhibit such apoptotic features. pp125^<FAK> focal adhesion kinase (FAK), was constitutively activated only in the v-src-transformed cells. Moreover, herbimycin A, a Src tyrosine kinase inhibitor, reduced tyrosyl phosphorylation of pp125^<FAK>, and reversed resistance to anoikis. These data suggest that pp60^<v-src> may substitute for integrin in the activation of pp125^<FAK>, thereby evading anoikis, and that the association of pp60^<src> with FAK might be required for acquisition of anchorage-independence. … More The functional role of ras in the acquisition of fully neoplastic potentials by v-src-transformed human gallbladder HAG/src3-1 cells, were investigated by introducing adenoviral vector containing dominant negative Ras (DN/Ras) into these cells. The anchorage-independent growth of the HAG/src3-1 was inhibted by DN/Ras by 93%. The HAG/src3-1 cells transfected with DN/ras failed to form tumors. Thus, v-src might requires a Ras-MAP kinase signaling cascade in the acquisition of tumorigenic potential. To examine the potential role of Rac, a small GTPase binding protein which acts downstream of Ras, experiments using adenovirus vectors containing DN/Ras or dominant negative Rac (DN/Rac), were performed. The data indicated that both DN/Ras and DN/Rac reduced the invasive potential of src-transfected cells by 60% and 99%, respectively, as compared to AdCALacZ containing β-gal gene as a control. Moreover, DN/Rac suppressed completely the tumorigenic potentials of src-transfected cells in nude mice. These results suggest that Src, Ras, Rac, all appeared to participate in the invasion processes, and that Rac may act downstream of these signaling pathways of invasion and tumorigenicity. Less
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Boudny V: "Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells."Anticancer Research. 19. 5203-5206 (1999)
Boudny V:“激活的 c-erbB-2 癌基因的表达会诱导人胆囊腺癌细胞对顺铂的敏感性。”抗癌研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koizumi W, Kurihara M, Nakano S, Hasegawa K: "Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer."Oncology. 58(3). 191-197 (2000)
Koizumi W、Kurihara M、Nakano S、Hasekawa K:“S-1(一种新型口服 5-氟尿嘧啶衍生物)在晚期胃癌中的 II 期研究。”肿瘤学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujishima H, Nakano S, Tatsumoto T, Masumoto N, Niho Y: "Interferon-a and -g inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing src tyrosine kinase activity."International J.Cancer. 76. 423-429 (1998)
Fujishima H、Nakano S、Tatsumoto T、Masumoto N、Niho Y:“干扰素-a 和 -g 通过降低 src 酪氨酸激酶活性来抑制 v-src 转化的人上皮细胞的生长和肿瘤潜能。”International J.Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okuma K: "Identification of a novel bovine serum protein involved in HTLV-1 omduced synsytium-" Archives of Virology. 144. 1-18 (1999)
Okuma K:“鉴定一种参与 HTLV-1 诱导合成的新型牛血清蛋白 -”病毒学档案。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masumoto N: "v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells"International Journal of Cancer. 80. 731-737 (1999)
Masumoto N:“v-src 通过增加人胆囊腺癌细胞中顺铂-DNA 链间交联的修复来诱导顺铂耐药”《国际癌症杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Mechanistic study for the anti-cancer effects of phytochemicals against breast and colon cancers
-
批准号:24501020
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:NAKANO Shuji
-
依托单位:
Basic and Epidemiological study for the carcinogenic role of obesity and nutritional factors in breast and colon cancers
-
批准号:20500734
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:NAKANO Shuji
-
依托单位:
Identification of signal transduction that induces anticancer drug resistance for clinical application
-
批准号:18590656
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.52万
-
财政年份:2006
-
负责人:NAKANO Shuji
-
依托单位:
MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL TRANSDUCTION IN THE INVASION POTENTIAL AND APOPTOSIS OF TUMOR CELLS
-
批准号:14570416
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:NAKANO Shuji
-
依托单位:
MECHANISTIC STUDY OF THE ROLE OF TYROSINE KINASE SIGNAL
-
批准号:12670427
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:NAKANO Shuji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: